The Gate Keeper Speaks: The FDA at the VentureWire Health Care Innovations Conference

September 12th, 2006 |

 
Share this post:
Facebook | Twitter | Google+ | LinkedIn | Pinterest | Reddit | Email
 
This post can be linked to directly with the following short URL:


 
The audio player code can be copied in different sizes:
144p, 240p, 360p, 480p, 540p, Other


 
The audio player code can be used without the image as follows:


 
This audio file can be linked to by copying the following URL:


 
Right/Ctrl-click to download the audio file.
 
Subscribe:
Connected Social Media - iTunes | Spotify | Google | Stitcher | TuneIn | Twitter | RSS Feed | Email
 

Patients desire improved treatments, voters call for safety, biomed startups want drug approval to continue in business and big pharma is after big profits. The Food and Drug Administration must grapple with these issues, which are only getting more complex. Dr. Steve Galson, director of the FDA’s Center for Drug Evaluation and Research, took the stage at the Dow Jones VentureWire Health Care Innovations 2006 in Redwood City, California, on September 12th, 2006. In this keynote interview Galson tells interviewer Brian Gormley — associate editor of the Dow Jones publication Venture Capital Analyst —what is on the mind of the FDA lately.

Tags: , , ,
 
Posted in: Connected Social Media, Dow Jones VentureWire, Healthcare, Tech Conferences and Events, Technology